Total Payments
$3,743
2024 Payments
$1,647
Companies
23
Transactions
268
Medicare Patients
7,469
Medicare Billing
$554,465
Payment Breakdown by Category
Food & Beverage$3,574 (95.5%)
Education$169.35 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,574 | 263 | 95.5% |
| Education | $169.35 | 5 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,040 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $438.75 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $389.55 | 19 | $0 (2024) |
| PFIZER INC. | $352.62 | 63 | $0 (2024) |
| Amgen Inc. | $333.97 | 21 | $0 (2024) |
| Lilly USA, LLC | $162.30 | 8 | $0 (2024) |
| LEO Pharma Inc. | $146.36 | 7 | $0 (2024) |
| Galderma Laboratories, L.P. | $139.12 | 9 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $136.31 | 9 | $0 (2018) |
| Genentech USA, Inc. | $110.23 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,647 | 103 | ABBVIE INC. ($397.98) |
| 2023 | $407.44 | 23 | AbbVie Inc. ($130.09) |
| 2022 | $45.56 | 3 | Janssen Biotech, Inc. ($30.22) |
| 2021 | $69.67 | 4 | Galderma Laboratories, L.P. ($30.05) |
| 2020 | $24.14 | 2 | Janssen Biotech, Inc. ($12.99) |
| 2019 | $546.47 | 53 | AbbVie, Inc. ($220.04) |
| 2018 | $557.69 | 53 | PFIZER INC. ($139.01) |
| 2017 | $445.29 | 27 | AbbVie, Inc. ($142.45) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Dermatology | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.87 | General |
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,165 | 1,784 | $367,772 | $88,174 |
| 2022 | 7 | 348 | 505 | $66,965 | $19,914 |
| 2021 | 13 | 2,599 | 5,962 | $543,172 | $166,603 |
| 2020 | 21 | 3,357 | 7,846 | $889,788 | $279,774 |
Total Patients
7,469
Total Services
16,097
Medicare Billing
$554,465
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 229 | $33,475 | $14,106 | 42.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 173 | 185 | $45,960 | $11,682 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $15,512 | $7,796 | 50.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 20 | 20 | $27,800 | $6,538 | 23.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 161 | 187 | $44,197 | $6,004 | 13.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 56 | $10,756 | $5,285 | 49.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 62 | 65 | $24,877 | $5,045 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 72 | 72 | $14,580 | $4,687 | 32.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 23 | 23 | $22,101 | $4,482 | 20.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 21 | 21 | $22,792 | $4,245 | 18.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 26 | 33 | $21,184 | $4,022 | 19.0% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 33 | 37 | $23,500 | $3,700 | 15.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 63 | 100 | $14,030 | $3,624 | 25.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 124 | 623 | $25,355 | $2,860 | 11.3% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 18 | 20 | $12,900 | $2,151 | 16.7% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 17 | $4,851 | $803.05 | 16.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $2,222 | $740.72 | 33.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,680 | $405.42 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 115 | 115 | $24,929 | $7,125 | 28.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 56 | 63 | $12,555 | $4,211 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 49 | $7,886 | $2,994 | 38.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 59 | 69 | $9,384 | $2,206 | 23.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 21 | 22 | $4,916 | $1,474 | 30.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 22 | 32 | $3,420 | $1,189 | 34.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 43 | 155 | $3,875 | $715.16 | 18.5% |
About Dr. Robert Walters, MD
Dr. Robert Walters, MD is a Dermatology healthcare provider based in Laurel, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548482482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Walters, MD has received a total of $3,743 in payments from pharmaceutical and medical device companies, with $1,647 received in 2024. These payments were reported across 268 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,574).
As a Medicare-enrolled provider, Walters has provided services to 7,469 Medicare beneficiaries, totaling 16,097 services with total Medicare billing of $554,465. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Laurel, MS
- Active Since 05/02/2007
- Last Updated 11/29/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1548482482
Products in Payments
- SKYRIZI (Biological) $427.86
- Humira (Biological) $395.38
- EUCRISA (Drug) $337.28
- COSENTYX (Drug) $331.02
- TREMFYA (Drug) $312.95
- Otezla (Drug) $220.64
- Finacea (Drug) $136.31
- DUPIXENT (Biological) $135.00
- TALTZ (Drug) $127.89
- Enbrel (Biological) $113.33
- RINVOQ (Biological) $106.48
- Skyrizi (Biological) $93.60
- Erivedge (Biological) $90.32
- COSENTYX (Biological) $85.00
- VTAMA (Drug) $66.22
- Sotyktu (Drug) $48.58
- EPIDUO FORTE (Drug) $47.08
- PICATO (Drug) $45.13
- Tremfya (Drug) $44.78
- ADBRY (Biological) $43.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.